Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity Sabrina T. WiebeAndreas D. MeidGerd Mikus Original Paper Open access 08 August 2020 Pages: 527 - 542
Well-tempered MCMC simulations for population pharmacokinetic models Frederic Y. BoisNan-Hung HsiehBrad Reisfeld Original paper 31 July 2020 Pages: 543 - 559
Application of Brunauer–Emmett–Teller (BET) theory and the Guggenheim–Anderson–de Boer (GAB) equation for concentration-dependent, non-saturable cell–cell interaction dose-responses Van Anh NguyenMurali Ramanathan Original Paper 08 August 2020 Pages: 561 - 572
Bolus pharmacokinetics: moving beyond mass-based dosing to guide drug administration Elie Sarraf Original Paper 18 August 2020 Pages: 573 - 581
The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery Agnieszka BienertPaweł SobczyńskiPaweł Wiczling Original Paper Open access 25 August 2020 Pages: 583 - 596
Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits David BussingDhaval K. Shah Original Paper 02 September 2020 Pages: 597 - 612
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment Francois MercierMarion KeriouiRene Bruno Original paper 31 August 2020 Pages: 613 - 625